ArticleBMC medical imaging2026
Bidirectional cortical gyrification alterations in chronic obstructive pulmonary disease: links to cognitive impairment and global initiative for chronic obstructive lung disease staging.
Article in BMC medical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Sulcal depth-based individualized structural covariance networks reveal multi-level brain reorganization associated with cognitive performance in COPD.Frontiers in neuroscience · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeCognitive impairment is a common but poorly understood comorbidity in chronic obstructive pulmonary disease (COPD). Although gray matter abnormalities have been observed in this population, the contribution of cortical gyrification-a structural feature linked to cognitive development and brain plasticity-remains unclear. This study aimed to characterize region-specific cortical gyrification alterations and examine their associations with domain-specific cognitive function and disease severity.
methodsWe enrolled 59 patients with stable COPD and 49 healthy controls who underwent pulmonary function testing, Montreal Cognitive Assessment, and high-resolution T1WI. The Toro's Gyrification Index quantified cortical gyrification. Group comparisons, partial correlations, and multiple linear regression analyses were conducted with adjustments for age, sex, and total intracranial volume.
resultsCompared with healthy controls, the patient group showed increased Toro's Gyrification Index in the bilateral superior temporal gyrus and left insula, and decreased values in the bilateral lingual gyri (P < .05). In the patient group, Toro's Gyrification Index in the left superior temporal gyrus was negatively correlated with abstract thinking (r = - .46, P = .003) and attention scores (r = - .39, P = .01). A regression model incorporating Toro's Gyrification Index in the left superior temporal and right lingual gyri explained 31% of the variance in abstract thinking score (F = 3.68, P = .004). The Global Initiative for Chronic Obstructive Lung Disease stage significantly predicted the right superior temporal gyrus Toro's Gyrification Index (F = 3.98, P = .002), with higher values observed in patients with disease stages 3 and 4 than stages 1 and 2 (F = 4.74, P = .005).
conclusionsCOPD is associated with region-specific, bidirectional cortical gyrification changes that are closely linked to cognitive impairment and disease severity. These findings suggest that gyrification-based metrics may offer a novel neuroimaging perspective for understanding brain reorganization in COPD. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.